XERS News and Press, Xeris Biopharma Holdings Inc.

Please replace the release issued earlier today with the following corrected version that provides additional information regarding the inducement grants. The corrected release reads: XERIS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) Xeris Biopharma Holdings, ...

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that on July 1, 2026, the Compensation Committee of Xeris’ Board o...

Chief Executive Officer John Shannon named Chair of the Board Marla Persky to transition to Lead Independent Director of the Board Board appoints Nerissa Kreher, M.D., effective July 1, 2026 Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast growing biopharmaceutical company ...

Patent expected to provide intellectual property protection for Keveyis through 2039 Reinforces Xeris’ commitment to the primary periodic paralysis community and the patients who rely on Keveyis Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Biopharma Holding...

2026-06-11 07:34:00 ET More on Xeris Pharmaceuticals Xeris Looks Ridiculously Cheap If Growth Forecasts Are Even Halfway Right Xeris Biopharma Holdings, Inc. (XERS) Q1 2026 Earnings Call Transcript Xeris forecasts $380M-$390M 2026 revenue as Recorlev commercial expan...

Eliminates approximately $23 million of debt, resulting in approximately $2 million in annual interest savings Principal to be paid in cash, remainder in common stock Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patie...

2026-05-30 23:31:08 ET ... Read the full article on Seeking Alpha For further details see: Xeris Looks Ridiculously Cheap If Growth Forecasts Are Even Halfway Right

2026-05-07 16:13:55 ET Image source: The Motley Fool. Thursday, May 7, 2026 at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-05-07 13:42:25 ET More on Xeris Pharmaceuticals Xeris Biopharma Holdings, Inc. (XERS) Q1 2026 Earnings Call Transcript Xeris Biopharma Holdings, Inc. (XERS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Xeris Biopharma: Undervalued Giv...

2026-05-07 13:41:22 ET Xeris Biopharma Holdings, Inc. (XERS) Q1 2026 Earnings Call May 7, 2026 8:30 AM EDT... Read the full article on Seeking Alpha For further details see: Xeris Biopharma Holdings, Inc. (XERS) Q1 2026 Earnings Call Transcript